Improving Cognition with Nutraceuticals Targeting TGF-β1 Signaling
Rescue of cognitive function represents an unmet need in the treatment of neurodegenerative disorders such as Alzheimer's disease (AD). Nutraceuticals deliver a concentrated form of a presumed bioactive(s) agent(s) that can improve cognitive function alone or in combination with current approve...
Saved in:
Main Authors: | Margherita Grasso (Author), Giuseppe Caruso (Author), Justyna Godos (Author), Angela Bonaccorso (Author), Claudia Carbone (Author), Sabrina Castellano (Author), Walter Currenti (Author), Giuseppe Grosso (Author), Teresa Musumeci (Author), Filippo Caraci (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Multimodal MOPr/DOPr Agonist LP2 Reduces Allodynia in Chronic Constriction Injured Rats by Rescue of TGF-β1 Signalling
by: Annamaria Fidilio, et al.
Published: (2021) -
The Therapeutic Potential of Novel Carnosine Formulations: Perspectives for Drug Development
by: Angela Bonaccorso, et al.
Published: (2023) -
Diet and Mental Health: Review of the Recent Updates on Molecular Mechanisms
by: Justyna Godos, et al.
Published: (2020) -
Low TGF-β1 plasma levels are associated with cognitive decline in Down syndrome
by: Margherita Grasso, et al.
Published: (2024) -
Prenatal stress induces a depressive-like phenotype in adolescent rats: The key role of TGF-β1 pathway
by: Annamaria Fidilio, et al.
Published: (2022)